Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function.

The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.

• Phase: N/A

Details

• Lead Sponsor: Assaf-Harofeh Medical Center
• Treatments: Acetylcysteine; N-monoacetylcystine

Criteria

Inclusion Criteria:

• Patients with ESRD, treated with chronic hemodialysis

Exclusion Criteria:

• Patients will be excluded from the study if they are:

1. Patients with acute renal failure

2. Currently treated with antioxidants ( NAC, vitamin E ets.)